We encourage individuals with type 2 diabetes who are considering Ozempic to consult with our experienced medical team
For availability context, When Retatrutide May Be Available reviews why development timelines and approval pathways can be uncertain
Nicholls SJ, Bhatt DL, Buse JB, Del Prato S, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Zoungas S, Basile J, Bartee A, Miller D, Nishiyama H, Pavo I, Weerakkody G, Wiese RJ, DAlessio DA, SURPASS-CVOT Investigators (2024) SURPASS-CVOT Investigators
It's called retatrutide, and what makes retatrutide different is that it targets not just one or two, but three hormone receptors in the pancreas: GLP-1, GIP, and glucagon
Lipid profiles (cholesterol and triglycerides) might improve more with dual agonists
2015 : Autorisation du liraglutide pour le traitement de lobsit, sous le nom de Saxenda